Youngpung Ranitidine Hydrochloride Tablet 150 mg
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Youngpung Pharmaceutical Co., Ltd.
MFDS item code 198701523 · Notified 1987.04.16
This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (ulcers, etc.); improvement of gastric mucosal lesions; prevention of Mendelson syndrome
This medicine is effective for gastrointestinal disorders such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered for preventive purposes before surgery to block Mendelson's syndrome and helps treat ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). It improves gastric mucosal damage, erosion, bleeding, redness, and swelling that occur during exacerbations of acute and chronic gastritis, and is used for upper gastrointestinal bleeding. It can also relieve burning sensations and regurgitation symptoms caused by excessive stomach acid, helping to improve gastric health. Thus, it effectively treats and improves various gastrointestinal disorders and symptoms.
Administer ranitidine 150 mg per dose twice daily, in the morning and at bedtime, by mouth. 1) Gastric and duodenal ulcers Administer this drug 150 mg per dose twice daily by mouth, or 300 mg once daily at bedtime. In particular, a higher healing rate can be achieved in patients with duodenal ulcers by administering 300 mg per dose twice daily, in the morning and at bedtime. The dosage and administration are the same when used in combination to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; for conditions caused by nonsteroidal anti-inflammatory drugs, healing usually occurs within 8 weeks, although the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer this drug 150 mg per dose twice daily for 8 weeks, or 300 mg once daily before bedtime. The dose may be increased to 150 mg per dose 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with this drug at 150 mg per dose 3 times daily; the dose may be increased as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation; once oral administration is possible, switch to this drug at 150 mg per dose twice daily. 5) Preanesthetic medication (prevention of Mendelson syndrome) Administer this drug 150 mg 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer this drug 150 mg once daily at bedtime. 7) Excess gastric acid, heartburn, and acid regurgitation: For patients aged 12 years and older, administer this drug 75 mg per dose twice daily by mouth (liquid formulation only). In patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. The dose may be adjusted according to age and symptoms.
For patients aged 8 〜 18 years, 150 mg per dose (2 mg per kg of body weight) may be administered up to twice daily.
This medication should not be used in patients who have had an allergic reaction to any component of the drug or in patients with a history of acute porphyria. In patients with impaired kidney function, this medication may remain in the body for an extended period, so it should be used cautiously by reducing the dose or prolonging the dosing interval. Careful attention is necessary for patients with weak liver function, those with a history of drug allergies, the elderly, and those taking NSAIDs. This medication may mask the symptoms of stomach cancer, so patients with gastric ulcers or those who have recently developed or changed dyspeptic symptoms, especially those over middle age, should confirm malignancy before using it. Patients with gastric or duodenal ulcers due to Helicobacter pylori must receive concurrent treatment to eliminate this bacterium. While taking this medication, rare but serious allergic reactions, blood abnormalities, liver dysfunction, heart issues, gastrointestinal symptoms, neurological issues, muscle pain, skin rashes, etc., may occur, and if symptoms appear, immediate consultation with a doctor is required. During treatment, regular blood tests and liver and kidney function tests should be performed to monitor the condition. The elderly or patients with chronic lung disease, diabetes, or weakened immunity should be cautious, as this medication may increase the risk of pneumonia. If dizziness or drowsiness occurs, it is safer to avoid driving or operating dangerous machinery. This medication may affect the absorption or excretion of other drugs, so if other medications are being taken, it is essential to inform the doctor or pharmacist. Women who are pregnant or may become pregnant should carefully consider the benefits and risks of using this medication, and nursing mothers should also consult a doctor before taking it. Safety has not been sufficiently established for children, so caution is needed. No particularly severe problems have been reported in cases of overdose, but appropriate treatment such as vomiting or gastric lavage may be necessary. Keep this medication out of the reach of children, and be careful not to transfer it to another container as that might compromise its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tight container protected from light and kept in a dry place at temperatures between 1 and 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication for a prolonged period.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Youngpung Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.